tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Promising Market Opportunity for Bicara Therapeutics in HPV-Negative Head & Neck Cancer Warrants Buy Rating
PremiumRatingsPromising Market Opportunity for Bicara Therapeutics in HPV-Negative Head & Neck Cancer Warrants Buy Rating
25d ago
Optimistic Buy Rating for Bicara Therapeutics: Superior Clinical Benefits and Valuation Upside
Premium
Ratings
Optimistic Buy Rating for Bicara Therapeutics: Superior Clinical Benefits and Valuation Upside
26d ago
Bicara Therapeutics initiated with a Buy at JonesResearch
Premium
The Fly
Bicara Therapeutics initiated with a Buy at JonesResearch
2M ago
Promising Clinical Developments and Financial Stability Drive Buy Rating for Bicara Therapeutics
PremiumRatingsPromising Clinical Developments and Financial Stability Drive Buy Rating for Bicara Therapeutics
2M ago
Bicara Therapeutics reports Q2 EPS (50c), consensus (54c)
Premium
The Fly
Bicara Therapeutics reports Q2 EPS (50c), consensus (54c)
2M ago
Bicara Therapeutics expects cash to fund operations into 1H of 2029
Premium
The Fly
Bicara Therapeutics expects cash to fund operations into 1H of 2029
2M ago
Morning News Wrap-Up: Friday’s Biggest Stock Market Stories!
PremiumMarket NewsMorning News Wrap-Up: Friday’s Biggest Stock Market Stories!
5M ago
Wells upgrades Bicara to Equal Weight with thesis played out
Premium
The Fly
Wells upgrades Bicara to Equal Weight with thesis played out
5M ago
Bicara Therapeutics upgraded to Equal Weight from Underweight at Wells Fargo
Premium
The Fly
Bicara Therapeutics upgraded to Equal Weight from Underweight at Wells Fargo
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100